Nonselective Beta-Adrenergic Blockade Augments Fasting Hyperkalemia in Hemodialysis Patients

Publisher： Karger

E-ISSN： 2235-3186|91|2|222-227

ISSN： 1660-8151

Source： Nephron, Vol.91, Iss.2, 2002-06, pp. : 222-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Influence of the Alpha-1-Adrenergic Receptor Blocker Doxazosin on Exercise-Induced Hyperkalemia in Hemodialysis Patients

By  

Kidney and Blood Pressure Research, Vol. 25, Iss. 1, 2002-02 ,pp. : 55-60

Karger

Access to resources Recommend Favorite

Membrane Flux Not Biocompatibility Determines Beta-2-Microglobulin Levels in Hemodialysis Patients

By  

Blood Purification, Vol. 20, Iss. 2, 2002-01 ,pp. : 161-166

Karger

Access to resources Recommend Favorite

Effects of Beta-Blocker Use on Volume Status in Hemodialysis Patients

By  

Blood Purification, Vol. 33, Iss. 4, 2012-06 ,pp. : 311-316

Karger

Access to resources Recommend Favorite

Elevation of Blood (1→3)-Beta-D-Glucan Concentrations in Hemodialysis Patients

By  

Nephron, Vol. 89, Iss. 1, 2001-08 ,pp. : 15-19

Karger

Access to resources Recommend Favorite

A Randomized Control Study on the Procedure for Switching Epoetin Beta (EPO) to Epoetin Beta Pegol (CERA) in the Treatment of Renal Anemia in Maintenance Hemodialysis Patients

By  

Blood Purification, Vol. 38, Iss. 3-4, 2014-12 ,pp. : 174-179

Karger

Access to resources Recommend Favorite